334 related articles for article (PubMed ID: 34827413)
21. Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.
Manto M; Mitoma H
Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137074
[TBL] [Abstract][Full Text] [Related]
22. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
Hadjivassiliou M; Manto M; Mitoma H
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
[TBL] [Abstract][Full Text] [Related]
23. Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration.
Degenhardt A; Duvoisin RM; Frennier J; Gultekin SH; Rosenfeld MR; Posner JB; Dalmau J
Neurology; 1998 May; 50(5):1392-7. PubMed ID: 9595993
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
25. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
Key RG; Root JC
Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
[TBL] [Abstract][Full Text] [Related]
26. Immune-mediated cerebellar ataxias: from bench to bedside.
Mitoma H; Manto M; Hampe CS
Cerebellum Ataxias; 2017; 4():16. PubMed ID: 28944066
[TBL] [Abstract][Full Text] [Related]
27. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
28. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
29. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
30. Hematologic malignancies and hematopoietic stem cell transplantation.
Briani C; Visentin A
Handb Clin Neurol; 2024; 200():419-429. PubMed ID: 38494294
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic cerebellar degeneration and dermatomyositis as first manifestations of underlying breast malignancy: a report of two cases and a brief review of the subject.
Ng YR; Ho CD; Ng WL; Tan SM
Surg Case Rep; 2015; 1(1):59. PubMed ID: 26366356
[TBL] [Abstract][Full Text] [Related]
32. [Paraneoplastic cerebellar degeneration].
Chabriat H; Chen QM; Poisson M; Delattre JY
Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
[TBL] [Abstract][Full Text] [Related]
33. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
34. Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.
Muñiz-Castrillo S; Vogrig A; Ciano-Petersen NL; Villagrán-García M; Joubert B; Honnorat J
Cerebellum; 2022 Aug; 21(4):573-591. PubMed ID: 35020135
[TBL] [Abstract][Full Text] [Related]
35. A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma.
Ayas ZÖ; Uncu G
Curr Oncol; 2021 Jan; 28(1):560-564. PubMed ID: 33477892
[TBL] [Abstract][Full Text] [Related]
36. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
Bruhnding A; Notch D; Beard A
J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
[TBL] [Abstract][Full Text] [Related]
37. Anti-Zic4 Paraneoplastic Cerebellar Degeneration With Mesial Temporal Lobe Hyperintensity in a Patient With Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.
Abuzahra S; Abuhassan A; Maree M; Makkawi M
Cureus; 2023 Mar; 15(3):e36164. PubMed ID: 37065299
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association.
Bhardwaj S; Khasani S; Benasher D; Stein EG; Meghal T; Jacoby N; Huang YJ
Cerebellum; 2019 Dec; 18(6):1126-1129. PubMed ID: 31161534
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
